Galderma Group AG announced its financial results for 2024, showcasing strong growth across all business segments. The company reported a net sales increase of 12.3% on a constant currency basis, reaching $2.72 billion. The continued expansion of its injectable aesthetics and dermatological skincare divisions drove this growth. Key financial highlights Core EBITDA surged by 26.6% to $651 million. The core ...